K. Omholt, E. Grafström, L. Kanter-lewensohn, J. Hansson, and B. K. Ragnarsson-olding, KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites, Clinical Cancer Research, vol.17, issue.12, pp.3933-3942, 2011.
DOI : 10.1158/1078-0432.CCR-10-2917
URL : http://clincancerres.aacrjournals.org/content/clincanres/17/12/3933.full.pdf

N. L. Schoenewolf, M. Urosevic-maiwald, and R. Dummer, Tumour heterogeneity of mucosal melanomas during treatment with imatinib, British Journal of Dermatology, vol.45, issue.Suppl., pp.419-424, 2011.
DOI : 10.1016/j.ejca.2008.10.026

M. Rouzbahman, S. Kamel-reid, A. Habeeb, M. Butler, J. Dodge et al., Malignant Melanoma of Vulva and Vagina, Journal of Lower Genital Tract Disease, vol.19, issue.4, pp.350-353, 2015.
DOI : 10.1097/LGT.0000000000000142

M. Saint-jean, G. Quéreux, J. Nguyen, L. Peuvrel, A. Brocard et al., Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?, Journal of Investigative Dermatology, vol.134, issue.5, pp.1468-1470, 2014.
DOI : 10.1038/jid.2013.378
URL : https://doi.org/10.1038/jid.2013.378

M. Saint-jean, G. Quereux, J. Nguyen, L. Peuvrel, A. Brocard et al., Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patients, Oncology Reports, vol.32, issue.2, pp.808-814, 2014.
DOI : 10.3892/or.2014.3265

A. Brocard, A. Knol, C. Bossard, M. G. Denis, G. Quéreux et al., Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients, Acta Dermato Venereologica, vol.97, issue.4, pp.483-488, 2017.
DOI : 10.2340/00015555-2568
URL : https://hal.archives-ouvertes.fr/inserm-01406472